Vol 10, No 2 (2016)
Review paper
Published online: 2016-11-29

open access

Page views 738
Article views/downloads 2386
Get Citation

Connect on Social Media

Connect on Social Media

What do we know about influence of opioids on immune system?

Iwona Filipczak-Bryniarska, Krzysztof Bryniarski
Medycyna Paliatywna w Praktyce 2016;10(2):59-65.

Abstract

Opioid effects on the immune system is a complex phenomenon which depends on the following variables: type of the opioid drug, the nature of the response (humoral or cellular), and the type of cells involved in its course. Macrophages appear to play an important role in modulating the signal of the opioid.

This is confirmed by the results of research conducted by a group of researchers from Krakow, which evaluated the effect of treatment with different opioids on the parameters of humoral and cellular immunity. While studies with morphine, fentanyl, and methadone has been completed, research on oxycodone and buprenorphine are still conducted. The work will be covered by the so far obtained results of experimental usage of these opioids.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Abbas AK, Lichtman AH, Pillai S. Immunologia. Funkcje i zaburzenia układu immunologicznego. Wydawnictwo Edra Urban & Partner, Wrocław 2015.
  2. Filipczak-Bryniarska I, Bryniarski K, Woroń J, et al. Mechanizmy przewodzenia bólu. Rola układu odpornościowego w regulacji odczuwania bólu. Anestezjol Ratown. 2010; 4: 99–108.
  3. Filipczak-Bryniarska I, Nowak B, Sikora E, et al. The influence of opioids on the humoral and cell-mediated immune responses in mice. The role of macrophages. Pharmacol Rep. 2012; 64(5): 1200–1215.
  4. Kaplan DH, Igyártó BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 2012; 12(2): 114–124.
  5. Nazimek K, Bryniarski K. The biological activity of macrophages in health and disease. Postępy Higieny i Medycyny Doświadczalnej. 2012; 66: 507–520.
  6. Nazimek K, Filipczak-Bryniarska I, Bryniarski K. Rola leków, egzosomów i cząsteczek miRNA w modulacji aktywacji immunologicznej makrofagów Postępy Hig. Med Dośw. 2015; 69: 1114–1129.
  7. Filipczak-Bryniarska I. Badania wpływu opioidów na aktywację nadwrażliwości kontaktowej i odpowiedź humoralną u myszy. Rola makrofagów. Praca doktorska. Uniwersytet Jagielloński Collegium Medicum, Wydział Lekarski Kraków, 2013.
  8. Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008; 8(4): 287–313.
  9. Coaccioli S, Di Cato L, Panaccione A, et al. Hydromorphone does not influence the immune response in patients affected by chronic pain. Clin Ter. 2013; 164(2): e97–e99.
  10. Güttler K, Sabatowski R. Differenzialtherapeutische Aspekte in der Schmerztherapie mit retardierten, oralen, stark wirksamen Opioiden. Der Schmerz. 2008; 22(5): 562–570.
  11. LeVier DG, Brown RD, Musgrove DL, et al. The effect of methadone on the immune status of B6C3F1 mice. Fundam Appl Toxicol. 1995; 24(2): 275–284.
  12. Limiroli E, Gaspani L, Panerai AE, et al. Differential morphine tolerance development in the modulation of macrophage cytokine production in mice. J Leukoc Biol. 2002; 72(1): 43–48.
  13. Meserve JR, Kaye AD, Prabhakar A, et al. The role of analgesics in cancer propagation. Best Pract Res Clin Anaesthesiol. 2014; 28(2): 139–151.
  14. Boland JW, Foulds GA, Ahmedzai SH, et al. A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function. BMJ Support Palliat Care. 2014; 4(4): 357–367.
  15. Boland JW, McWilliams K, Ahmedzai SH, et al. Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review. Br J Cancer. 2014; 111(5): 866–873.
  16. Liang X, Liu R, Chen C, et al. Opioid System Modulates the Immune Function: A Review. Transl Perioper Pain Med. 2016; 1(1): 5–13.
  17. Nazimek K, Kozlowski M, Bryniarski P, et al. Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages. Exp Biol Med (Maywood). 2016; 241(14): 1540–1550.
  18. Nelson CJ, Lysle DT. Morphine modulation of contact hypersensitivity response: characterization of immunological changes. Clin Immunol. 2001; 115: 101–110.
  19. Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008; 2(1): 14–18.
  20. Lefkowitz SS, Chiang CY. Effects of certain abused drug s on hemolysin forming cells. Life Sci. 1975; 17(12): 1763–1767.
  21. Filipczak-Bryniarska I., Nazimek K., Nowak B., Woroń J., Wordliczek J., Bryniarski K. Buprenorphine, but not oxycodone, enhances humoral immune response in mice by activation of macrophages. Abstracts of the 4 th European Congress of Immunology — ECI 2015. Vienna, Austria: 386–387 Vienna, 2015.
  22. Laudenbach M, Baruffaldi F, Vervacke JS, et al. The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse. J Immunol. 2015; 194(12): 5926–5936.
  23. Delgado-Vélez M, Lugo-Chinchilla A, Lizardo L, et al. Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state. J Neuroimmunol. 2008; 196(1-2): 94–100.
  24. Vassou D, Bakogeorgou E, Kampa M, et al. Opioids modulate constitutive B-lymphocyte secretion. Int Immunopharmacol. 2008; 8(5): 634–644.
  25. Yahya MD, Watson RR. Immunomodulation by morphine and marijuana. Life Sci. 1987; 41(23): 2503–2510.
  26. Tahamtan A, Tavakoli-Yaraki M, Mokhtari-Azad T, et al. Opioids and Viral Infections: A Double-Edged Sword. Front Microbiol. 2016; 7: 970.



Palliative Medicine in Practice